12 Health Care Stocks Moving In Monday's After-Market Session

Benzinga · 07/14 21:05
Gainers
- Quanterix (NASDAQ:QTRX) stock rose 7.9% to $6.53 during Monday's after-market session. The company's market cap stands at $274.7 million.
- Atlantic International (NASDAQ:ATLN) stock increased by 7.79% to $2.35. The company's market cap stands at $133.7 million.
- AngioDynamics (NASDAQ:ANGO) stock increased by 7.29% to $10.29. The market value of their outstanding shares is at $378.4 million.
- NewGenIvf Group (NASDAQ:NIVF) stock moved upwards by 7.23% to $0.68. The company's market cap stands at $2.7 million.
- Acurx Pharmaceuticals (NASDAQ:ACXP) shares moved upwards by 7.01% to $0.49. The market value of their outstanding shares is at $11.1 million.
- 60 Degrees (NASDAQ:SXTP) shares increased by 6.69% to $2.31. The market value of their outstanding shares is at $3.7 million.
Losers
- Organogenesis Holdings (NASDAQ:ORGO) shares fell 31.0% to $3.1 during Monday's after-market session. The company's market cap stands at $545.4 million.
- MiMedx Group (NASDAQ:MDXG) shares fell 20.48% to $5.4. The market value of their outstanding shares is at $981.4 million.
- Rani Therapeutics Hldgs (NASDAQ:RANI) shares declined by 14.07% to $0.6. The market value of their outstanding shares is at $25.2 million.
- VSee Health (NASDAQ:VSEE) shares fell 12.95% to $1.21. The company's market cap stands at $19.2 million.
- Talphera (NASDAQ:TLPH) stock decreased by 11.86% to $0.42. The company's market cap stands at $10.6 million.
- Rallybio (NASDAQ:RLYB) shares declined by 8.4% to $0.4. The market value of their outstanding shares is at $16.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.